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Natural killer T (NKT) cells play an important role in
mounting protective responses to blood-borne infections.
However, though the spleen is the largest blood ﬁlter in
the body, the distribution and dynamics of NKT cells
within this organ are not well characterized. Here we
show that the majority of NKT cells patrol around the
marginal zone (MZ) and red pulp (RP) of the spleen. In
response to lipid antigen, these NKTcells become arrested
and rapidly produce cytokines, while the small proportion
of NKTcells located in the white pulp (WP) exhibit limited
activation. Importantly, disruption of the splenic MZ by
chemical or genetic approaches results in a severe reduc-
tion in NKT cell activation indicating the need of coopera-
tion between both MZ macrophages and dendritic cells for
efﬁcient NKT cell responses. Thus, the location of splenic
NKT cells in the MZ and RP facilitates their access to
blood-borne antigen and enables the rapid initiation of
protective immune responses.
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Introduction
NKT cells are a heterogeneous subset of classical ab T
lymphocytes that share the common characteristic of being
restricted by the MHC class I-like molecule CD1, which can
present self and foreign lipids (Barral and Brenner, 2007;
Bendelac et al, 2007). As such, NKT cells can be directly
activated in response to lipids from several bacteria (like
Shingomonas, Erlichia, Borrelia or Streptococcus; Kinjo et al,
2005, 2006, 2011; Mattner et al, 2005) or in response to
endogenous lipid antigens upregulated in antigen
presenting cells (APCs) after TLR stimulation (Brigl et al,
2003; Paget et al, 2007; Salio et al, 2007). The activation of
NKT cells by these two mechanisms explains their
involvement in a broad range of immune responses against
viruses, bacteria, fungus, anti-tumour immunity and
autoimmune processes (Bendelac et al, 2007; Tupin et al,
2007; Cerundolo et al, 2009). Upon activation, NKT cells
rapidly secrete large amounts of cytokines and induce
downstream activation of different cell types, including
dendritic cells (DCs), NK cells, B cells and conventional T
cells. On this basis, NKTcells have been described as a bridge
between innate and adaptive immune responses (Bendelac
et al, 2007).
In recent years, various studies have highlighted the parti-
cular importance of NKT cells in responding to blood-borne
pathogens and these cells have been shown to accumulate in
the vasculature of both lung and liver (Geissmann et al, 2005;
Vela ´zquez et al, 2008; Lee et al, 2010; Scanlon et al, 2011).
However, in spite of the fact that the spleen is the major site
where immune responses to blood-borne antigens are
initiated (Mebius and Kraal, 2005), little is currently
understood about where NKT cells are located and their
dynamic features in this organ. Indeed, due to the technical
difﬁculties associated with unambiguous identiﬁcation of
these cells using immunohistochemistry (Berzins et al,
2005), the distribution of endogenous NKT cells in the
spleen has remained an open question in the ﬁeld.
The spleen is highly structured and composed of the red
pulp (RP) that acts mainly as a blood ﬁlter, and the white
pulp (WP) where the majority of B and T lymphocytes reside,
separated by the marginal zone (MZ). The MZ contains a
specialized subset of MZ B cells, DCs and two subsets of
macrophages: MZ macrophages characterized by the expres-
sion of the surface receptors SIGN-R1 and/or MARCO
(Elomaa et al, 1995; Geijtenbeek et al, 2002), and
metallophilic macrophages expressing sialoadhesin (CD169,
Siglec-1 (Kraal and Janse, 1986)). Arterial branches in the
spleen terminate in the marginal sinus, allowing blood to
transit through the MZ and into the RP (Mebius and Kraal,
2005). This organization allows cells in the MZ to be in
continuous contact with blood-borne antigens and indeed,
MZ B cells and macrophages have been described as
main players in the initiation of immune responses against
blood-borne pathogens (Martin et al, 2001; Aichele et al,
2003; Kang et al, 2004). The MZ is a very complex structure
in which the various intercellular interactions appear to be
critical for the organization and function of the individual cell
types. However, the precise role of the MZ populations,
particularly in antigen presentation during the initiation of
immune responses, remains unclear (Ciavarra et al, 1997;
Aichele et al, 2003; Backer et al, 2010; You et al, 2011).
Here, we have used a combination of pulse-labelling,
immunoﬂuorescence and multi-photon microscopy to show
that the majority of splenic NKT cells localize to and patrol
around the MZ and RP. In response to lipid antigen, these NKT
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in the MZ and become activated to secrete cytokines. In
contrast, NKT cells located in the periarteriolar lymphoid
sheath (PALS) showed limited activation. Moreover, the
disruption of macrophages and dendritic cells in the MZ
dramatically reduces NKT cell activation, suggesting that the
cooperation of cells in the MZ is necessary for efﬁcient NKT
cell responses.
Results
NKT cells are highly accessible to the blood entering the
spleen
Since the role of NKTcells in response to blood-borne antigen
has been well established, we sought to examine the acces-
sibility of NKT cells to the blood entering the spleen as an
indication of their location. To do this, we adapted an in vivo
pulse-labelling procedure that allows the selective labelling
of cells according to their exposure to the blood (Figure 1;
Cinamon et al, 2008; Pereira et al, 2009; Muppidi et al, 2011).
Mice were intravenously (i.v.) injected with phycoerythrin-
labelled anti-CD45 antibody (CD45-PE) and spleen sections
were imaged by confocal microscopy (Figures 1A and B). As
expected, the MZ region became highly labelled after a brief
(3min) exposure to CD45-PE, while no staining was detected
in the WP that was protected from antibody arrival
(Figure 1A). In line with this, ﬂow cytometric analysis of
the extent of CD45-PE labelling in total splenocytes revealed
that a large proportion of MZ B cells (B220
þCD21
hiCD23
lo)
were highly labelled with CD45-PE compared with follicular
B (B220
þCD21
loCD23
hi) and T cells (Figure 1A). Using this
approach, we observed that the majority of splenic NKTcells,
identiﬁed as either TCR-b
þaGalCer-CD1d tetramer
þB220
 
cells (Figure 1A) or TCR-b
þNK1.1
þB220
  cells (Figure 1D),
were highly labelled with CD45-PE (72±7% and 75±5%,
respectively), indicating their proximity to the blood supplied
to the spleen. Unlike MZ B cells, the proportion of NKTcells
labelled after longer (20min) antibody treatments remains
stable (Figures 1B and C), although the mean ﬂuorescence
intensity (MFI) of labelling in the NKT population increased
over time (Figure 1C). Interestingly, we did not observe
striking phenotypical differences between highly and poorly
in vivo labelled NKT cells in terms of the expression of CD4,
CD8, DX5, CD44, CD122, NK1.1 and CD62L, although CD69
expression seemed to be higher in CD45-PE
þ NKT cells
(Supplementary Figure S1).
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Figure 1 Splenic NKTcells are accessible to the blood entering the spleen. (A–D) Mice were injected with CD45-PE antibody 3min (A, C, D)o r
20min (B, C) before analyses. (A, B) Immunoﬂuorescence (left) from spleens of mice injected with CD45-PE (red) stained with CD169 (blue).
Bars, 50mm. Flow cytometry for CD45-PE binding by splenic MZ B cells, Tcells and NKTcells (black line; grey solid proﬁle, un-injected control)
(C) MFI (left) and percentage of cells (right) binding to CD45-PE in the referred splenic populations at 3 and 20min after injection. Each dot
represents an individual animal. (D) Flow cytometry of B220
  splenocytes showing TCR-b and NK1.1 (left), and binding of CD45-PE by
TCR  b
þNK1.1
þB220
  cells (right). Data represent 5 independent experiments with 2 mice per experiment.
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cells are readily accessible to blood entering the spleen,
suggesting that they reside outside the splenic WP.
NKT cells are preferentially located in the splenic MZ
and RP
We moved on to directly visualize the distribution of endo-
genous NKT cells in the spleen and initially adopted an
approach using CD1d tetramer staining of splenic frozen
sections. However, consistent with previous reports, this
proved technically challenging (Berzins et al, 2005; Thomas
et al, 2011) and as a result of high levels of background
staining we were unable to unambiguously identify
endogenous NKT cells. To overcome this, we have used two
alternative strategies to elucidate the distribution of splenic
NKTcells. First, endogenous NKTcells were identiﬁed in situ
in ﬂash-frozen cryostat sections of spleens of mice previously
perfused with neutral buffered formalin (Figures 2A and B;
Supplementary Figure S2; Andrews et al, 2001). This method
allows discrimination of TCR-b
þNK1.1
þ NKT cells from NK
cells (NK1.1
þTCR-b
 ) and conventional T cells (TCR-
b
þNK1.1
 ). However, as both TCR and NK1.1 can be
down-regulated in activated NKT cells, we have used a
second, complementary strategy involving the adoptive
transfer of highly puriﬁed NKT cells into congenic recipients
(Figures 2C and D; Supplementary Figure S2; Barral et al,
2010).
Importantly, both endogenous (n¼247) and adoptively
transferred (n¼81) NKTcells occupied a similar distribution
within the splenic sections. We observed that splenic NKT
cells were predominantly located in the RP, MZ and T cell
areas (47%, 25 and 23%, respectively) but virtually excluded
from B cell follicles. In order to compare the relative distribu-
tion of NKT cells amongst splenic regions, the proportion
of NKT cells was related to the cross-sectional area of
each region (Supplementary Figures S2C and D, previously
reported (Aoshi et al, 2008)). This type of analysis revealed
the preferential accumulation of NKTcells in the MZ (Figures
2B and D). Notably, the total proportion of NKTcells present
in the RPand MZ (B70%), and therefore readily accessible to
the blood entering the spleen, is equivalent to the percentage
of endogenous NKT cells labelled by in vivo antibody injec-
tion (Figure 1A). Similarly, the majority of adoptively trans-
ferred NKTcells were highly stained after pulse-labelling with
CD45-PE (B72%), conﬁrming that they occupy a similar
distribution in the spleen than that of endogenous cells
(Figure 2E).
To characterize the spatiotemporal dynamics of NKT cells
in the spleen we have used time-lapse multi-photon micro-
scopy. This method presents important technical difﬁculties
since the maximum imaging depth achievable in the spleen is
severely hampered by the absorption and scattering of light
by blood. However, as the majority of NKTcells are excluded
from the PALS, we imaged the spleen directly through the
collagen capsule (to a maximum depth of 70mm), which
allowed us to visualize NKT cells outside the WP (Figures
2F–J, Supplementary Movies S1 and S2). Under these condi-
tions, we observed that splenic NKT cells migrate with an
average speed of 6.2±2.7mm/min (Figure 2G). The distribu-
tion of instantaneous speeds for NKTcells showed maximum
values of around 20mm/min and low arrest coefﬁcients
(13%) similar to those measured for conventional T cells
(10%; Figures 2H and I). To visualize NKT cells located in
deeper regions of the spleen (MZ and PALS) we performed an
alternative imaging approach by cutting open the spleen
across the transverse axis and placing the tissue in warm
oxygenated medium for imaging (as previously reported
(Aoshi et al, 2008; Baje ´noff et al, 2008)). Under these
imaging conditions NKT cells showed comparable dynamics
to those of NKT cells visualized in intact spleen (average
speed, 5.9±0.4mm/min; arrest coefﬁcient, 13%; Supple-
mentary Figure S3, Supplementary Movie S3).
Therefore, splenic NKT cells predominantly reside in the
MZ and RPand patrol the resting spleen with similar dynamic
features as those observed for conventional T cells.
NKT cells are activated by blood-borne lipid antigen
outside the WP
The observed location of splenic NKTcells renders them in an
ideal position to sense circulating antigen in its arrival to the
spleen (Mebius and Kraal, 2005). Therefore we have used
different approaches in order to investigate the behaviour of
splenic NKT cells in response to antigen administration.
To mimic conditions occurring during infection with
bacteria encoding NKT cell agonists we injected mice i.v.
with particles (200nm diameter) coated with either a-linked
galacturonic glycosphingolipid (GalA-GSL) from Sphingomonas
yanoikuyae or aGalCer (Kinjo et al, 2005; Mattner et al, 2005;
Barral et al, 2010).
We observed that the majority of splenic NKT cells were
activated to produce IFN-g and IL-4, within 2h of i.v. injec-
tion with bacterial lipids (Figure 3A). A similar activation was
observed following administration of particulate aGalCer
while no cytokine production was detected after injection of
control lipids (Figure 3A). Next we examined the distribution
of both endogenous and adoptively transferred NKT cells
2h after i.v. administration of lipid antigen (Figures 3B–D,
Supplementary Figure S4A and B). At this time, we observed
that the proportion of NKT cells in the splenic MZ increased
(25±4% to 38±4%, n¼187, Figures 3C and D). However,
the total proportion of NKT cells outside the splenic WP did
not signiﬁcantly change following antigen administration
(B70%, Figures 3C and D), suggesting that cells relocate
from the RP into the splenic MZ.
Although the majority of NKTcells localize in the MZ after
antigen administration still a number of cells remained in the
WP. Therefore we sought to investigate a potential relation-
ship between NKTcell location and their activation status by
extending the in vivo pulse-labelling approach. Two hours
after i.v. injection of particulate lipid antigen, mice received a
3min pulse of CD45-PE and the extent of labelling was
correlated with the activatory status of NKT cells (Figure 4).
Notably, in response to either bacterial-derived GalA-GSL or
aGalCer, the majority of NKT cells that were activated to
secrete IL-4 and IFN-g were highly labelled in vivo with CD45-
PE. In contrast, those NKT cells located in the WP that were
protected from CD45-PE labelling, exhibited very limited
activation. Comparably, i.v. administration of soluble
aGalCer induced the same kind of differential activation in
NKT cells located inside or outside the splenic WP
(Supplementary Figures S4C–F).
Thus, the localization of NKT cells outside the splenic WP
promotes their early activation in response to blood-borne
antigen arrival.
NKT cells are activated outside splenic white pulp
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Since NKTcell activation takes place within hours of antigen
administration we asked the question of where blood-borne
particulate lipids localized on their arrival to the spleen. The
location of ﬂuorescently labelled particulate lipids in the
spleen was tracked using confocal microscopy of frozen
sections (Figure 5A). Two hours after i.v. administration,
lipid antigen was predominantly located in the MZ and
co-localized with MARCO
þ and SIGN-R1
þ MZ macrophages
and CD11c
þ DCs (Figure 5A). Importantly, we observed that
endogenous NKT cells were also situated in the MZ and
appeared in close proximity to cells containing particulate
GalA-GSL and aGalCer (Figures 5B and C).
In order to understand the effect of antigen arrival in NKT
cell dynamics we imaged the spleen by multi-photon micro-
scopy 2h after antigen administration. At this time point we
observed that NKTcells stopped their migration and became
conﬁned in antigen-rich regions (Figures 5D–I, Supple-
mentary Movies S4 and S5). Consequently we measured a
decrease in the average speed of NKTcells (3.7±2.5mm/min
versus 6.2±2.7mm/min in the absence of antigen; Figure 5E)
that was accompanied by an increase in arrest coefﬁcient
(56% versus 13%; Figure 5H). In contrast, the average speed
and arrest coefﬁcient observed for conventional T cells was
not changed following lipid antigen administration
(6.2±1.9mm/min and 13.4%, respectively; Figures 5D–I).
The alteration of the dynamic behaviour of splenic NKT
cells in response to lipid antigen is similar to that reported
for NKT cells both in lymph nodes and liver, suggesting that
their migration provides a means of immune surveillance
in tissues (Geissmann et al, 2005; Barral et al, 2010; Lee
et al, 2010).
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Figure 2 Splenic NKTcells are predominantly located in the MZ and RP. (A–D) Immunoﬂuorescence from spleen sections stained with B220
(cyan), CD169 (green), TCR-b (red) and NK1.1 (blue, A) or CD45.2 (blue, C). White dots depict NKTcells. Bars, 200mm. (B, D) Percentages
(left) and proportion of cells per area (right) of NKTcells in the RP, MZ, B cell follicles (B) and PALS (T) for endogenous (B) and adoptively
transferred (D) NKTcells. (E)2 10
6 sorted NKTcells were labelled with CellTrace Violet (CTV) and injected into WT mice. 16h later recipients
were injected with CD45-PE 3min before analysis. Transferred cells were detected in the recipient spleen as CTV
þ cells (left) and showed high
CD45-PE labelling (right). (F, top) Multi-photon microscopy image of the spleen showing collagen capsule (blue) and NKTcells (red). Tracks for
individual cells are depicted in pink. Bar, 50mm. (F, bottom) Snapshot images showing NKTcells (red) and Tcells (blue) at the indicated time
points. Individual cell tracks are coloured in pink (NKTcells) and blue (Tcells). Stamp, min:sec. Bars, 20mm. (G–J) Average speed (G), speed
distribution (H), arrest coefﬁcient (I) and migratory tracks (J) for NKTcells and Tcells. Each dot represents an individual cell. Data were pooled
from 2 independent experiments with 2 mice each. p, unpaired two-tailed t-test.
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The identity of the APCs that participate in the initiation of
NKT cell activation in the spleen is largely unknown.
To assess the ability of primary splenic DCs and MZ macro-
phages to retain lipid antigens arriving to the spleen we
injected mice with ﬂuorescent particulate lipids and 2h
later we analysed antigen retention by splenic cell popula-
tions by ﬂow cytometry. At this time point around 50% of
DCs and SIGN-R1
þ MZ macrophages were found to retain
particulate lipids after in vivo injection (Figures 6A and B).
Importantly, both of these cell types showed high expression
of CD1d (Figures 6C and D).
Subsequently, we went on analysing the ability of MZ
macrophages and DCs to stimulate NKT cell activation
in vitro. To this end, SIGN-R1
þ macrophages and CD11c
hi
DCs were enriched from splenic single cell suspensions by
depletion of B and T cells and further puriﬁed by ﬂow
cytometry sorting (Figure 6E). After pre-incubation for 2h
with particulate lipids, sorted cells were co-cultured with
NKT cell hybridoma DN32.D3 cells. As shown in Figure 6F
aGalCer was efﬁciently presented by both DCs and SIGN-R1
þ
cells, as measured by IL-2 production by DN32.D3 cells,
with DCs showing a stronger presentation capacity than
macrophages.
Thus, DCs and MZ macrophages retain lipid antigen on its
arrival to the spleen and they can efﬁciently present lipids to
mediate NKT cell activation.
NKT cell activation depends on the integrity of the MZ
To investigate the role of DCs and macrophages in mediating
NKT cell activation in vivo we have used two different
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Figure 3 NKT cell activation in response to lipid antigen (A) Intracellular IFN-g (top) and IL-4 (bottom) staining for splenic NKTcells (TCR-
b
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 ) 2h after injection of particulate control lipids (left), GalA-GSL (middle) or aGalCer (right). (B–D) Confocal
microscopy identiﬁcation of endogenous NKT cells 2h after antigen injection. (B) Spleen sections were stained with B220 (cyan), CD169
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tions present in the spleen.
Firstly, mice were treated with clodronate liposomes (CLL)
to selectively deplete macrophages in the MZ and RP.
However, in line with previous reports (Aoshi et al, 2008),
two days after CLL treatment we observed a depletion not
only of MARCO
þ, SIGN-R1
þ, F4/80
þ and CD169
þ cells but
also a reduction in CD11c
hi cells (Figure 7A, Supplementary
Figure S5A–E). Concomitant with the loss of these cells,
antigen was not efﬁciently retained in the splenic MZ and
was instead dispersed throughout the RP. Moreover, at this
time we detected a dramatic decrease in the percentage of
NKT cells that were activated to secrete IFN-g (23±5%
versus 69±3%; Figure 7B, Supplementary Figure S5E),
accompanied by a decrease in MFI for intracellular IFN-g
secreted by NKT cells (46±13% MFI reduction after CLL
treatment versus untreated mice).
As the DC population recovers more rapidly than macro-
phages after CCL administration, we went on to assess the
contribution of these populations in NKT cell activation six
days after CCL treatment which allows recovering of DCs
while macrophages remain absent (Figures 7C and D,
Supplementary Figure S5F–H). At this time, antigen was not
efﬁciently retained at the MZ however we detected that a
substantial proportion of NKT cells recovered their ability to
secrete cytokines after antigen injection (46±9% IFN-g
þ
NKT cells; 28±18% MFI reduction for IFN-g after CLL treat-
ment versus untreated mice; Figure 7D, Supplementary
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mediating NKT cell activation. At later times after CLL treat-
ment (16 days) we found that DC numbers were equivalent to
those of WT mice and the populations of F4/80
þ and
MARCO
þ macrophages started to recover, with cells appear-
ing scattered through the RP and partially colocalizing with
injected particulate lipids (Figures 7E and F, Supplementary
Figure S5I–K). However CD169
þ and SIGN-R1
þ cells
remained absent (Supplementary Figure S5I). Despite the
reappearance of some macrophage populations, the extent
of NKT cell activation after antigen injection (41±4% IFN-g
NKT cells, Figure 7F) was still comparable to the one mea-
sured at 6 days after CLL treatment suggesting that the
positioning of the different macrophage populations in the
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quent NKT cell activation. Twenty two days after CLL treat-
ment we observed a complete recovery of all macrophage
populations, accompanied by an efﬁcient antigen retention in
the MZ and full recovery of NKTcell activation (60±4% IFN-g
NKTcells; Figures 7G and H).
Finally, to further delineate the cellular requirements for
splenic NKTcell activation, we took advantage of the CD11c-
DOG model that allows depletion of CD11c
þ cells after
injection of diphtheria toxin (DT; Hochweller et al, 2008).
Two days after DT treatment, we observed not only complete
ablation of DCs, but also depletion of both MZ and RP
macrophages while the population of MZ B cells didn’t
appear to change substantially (Figure 7I; Supplementary
Figure S5L–O; Hochweller et al, 2008). This depletion was
accompanied by a reduction in antigen retention at the MZ
and a dramatic decrease in NKTcell activation following lipid
administration (23±2%; Figures 7I and J; Supplementary
Figure S5L-N). Intriguingly, even in the absence of DCs and
macrophages, around 20% of NKT cells were activated to
secrete IFN-g suggesting that other APCs such as B cells may
also participate in NKT cell activation in the spleen.
Discussion
In this study we show that the majority of splenic NKT cells
are located in the MZ and RP, with only a small proportion of
cells located in the WP. Shortly after administration, lipid
antigens were retained in the MZ by macrophages and DCs,
where they trigger NKTcell activation. In contrast, NKTcells
located in the PALS have restricted access to antigen and
therefore exhibit limited secretion of cytokines. Disruption of
macrophages and DCs within the MZ compartment reduces
the extent of NKT cell activation, suggesting that these
populations cooperate to trigger effective NKTcell responses.
Despite the fact that the spleen is one of the preferential
locations for NKT cells in the body, the distribution and
dynamics of NKT cells in this organ have remained unclear
because of the technical difﬁculties often associated with
unambiguous identiﬁcation of NKT cells in situ and limited
imaging depth possible in this blood-rich organ (Berzins et al,
2005; Aoshi et al, 2008; Baje ´noff et al, 2010). Recently CD1d
tetramer staining has been used to visualize NKTcells in the
spleen of Va14 transgenic mice, with cells appearing located
mainly in the PALS (Thomas et al, 2011). However in line
with our observations, the authors were unable to
unambiguously identify individual splenic NKT cells in WT
mice by tetramer staining. To overcome this we have used
two complementary strategies to examine the location of both
endogenous and adoptively transferred NKT cells. By using
these two approaches we conﬁrmed the presence of a
proportion of NKT cells in the PALS (B30%) though the
majority of NKTcells appear scattered around the MZ and RP
of the spleen. In steady-state conditions, NKTcells patrol the
spleen with an average speed of around 6.2mm/min, similar
to that observed for CD8
þT cells in the WP (B5mm/min;
Aoshi et al, 2008). These speeds are slower than those
reported for equivalent cells in lymph nodes (Aoshi et al,
2008; Barral et al, 2010) suggesting that the environmental
differences between tissues might affect the cell motility.
Since NKT cells are located in blood-rich regions of the
spleen we cannot discard that the lack of blood ﬂow in
splenic explants may lead to alterations in cell behaviour.
However the data obtained so far for lymphocyte dynamics in
A
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intra-vital microscopy of surgically exposed tissues (Huang
et al, 2004).
The observed distribution of splenic NKT cells has impor-
tant implications for our understanding of how these cells are
involved in mounting responses to blood-borne antigen.
Indeed the continuous exposure of MZ cells to bacterial and
viral antigens in the circulation facilitates rapid responses
and successful control of infection (Mebius and Kraal, 2005).
As such, the location of the majority of NKT cells in close
proximity to blood entering the spleen facilitates the rapid
encounter of patrolling NKT cells with antigen. In concert,
as NKT cells typically present an activated/memory-like
phenotype this ensures very rapid secretion of cytokines
after antigen encounter, promoting protective responses. In
line with this suggestion, lung and liver NKT cells have also
been detected in an intravascular location, which may allow
the rapid sensing of blood-borne antigens in those tissues
(Geissmann et al, 2005; Vela ´zquez et al, 2008; Lee et al,
2010).
The localization of NKT cells in the MZ might also play a
role in the initiation of rapid adaptive immune responses.
Like NKT cells, MZ B cells have been implicated in early
immune responses, as they are responsible for the ﬁrst wave
of antibody secretion in response to bacterial antigen (Martin
et al, 2001) and mediate more rapid responses against blood-
borne viral particles compared with follicular B cells (Gatto
et al, 2004). Interestingly, MZ B cells express higher levels of
CD1d than follicular B cells and are more efﬁcient than
follicular B cells in presenting antigen to NKT cells (Galli
et al, 2003; Barral et al, 2008; Leadbetter et al, 2008; Chang
et al, 2012; King et al, 2012). Moreover it has been recently
suggested that interactions between MZ B cells and NKTcells
might play a role in vivo to boost CD1-dependent immune
responses (Muppidi et al, 2011). Indeed, many bacteria
contain repetitive epitopes in their surface and/or lipid
antigens that can favour internalization by speciﬁc MZ B
cells and subsequent interaction with splenic NKT cells to
allow early antibody responses.
Traditionally the location of effector T cells has been
examined by visualizing their spatial distribution in static
snapshots of tissues. Though informative, such approaches
provide little information as to the relationship between
location and effector function. To overcome these limitations,
we used a combination of multi-photon microscopy, ﬂow
cytometry and immunohistochemistry to examine where
splenic NKT cell activation occurs in vivo. In response to
lipid antigen, we observed that concomitant with rapid
activation to secrete cytokines, splenic NKT cells became
arrested in close proximity to antigen-containing cells,
a common feature associated with T cell activation
(Cahalan and Parker, 2008). Importantly, activation was
more evident in NKT cells in close proximity to blood
entering the spleen, suggesting that antigen presentation
occurs predominantly outside the WP. Interestingly, we
obtained similar NKT cell activation pattern upon injection
of soluble lipids. This is probably due to the association of
blood-borne aGalCer with apolipoproteins forming lipid
transport particles that will not have access to the splenic
conduit system and will therefore be retained in the MZ
(Nolte et al, 2003; van den Elzen et al, 2005; Barral and
Brenner, 2007). NKT cell activation in the MZ resembles the
response of memory CD8
þ Tcells that cluster in the MZ and
RP early in response to infection (Baje ´noff et al, 2010; Kurachi
et al, 2011). In contrast, it has been reported that the
activation of conventional T cells takes place mainly in the
PALS during bacterial infection (Khanna et al, 2007; Aoshi
et al, 2008). In this scenario, DCs transport bacteria from the
MZ into the PALS and present antigen to speciﬁc CD8
þT
cells, though this takes place over several hours (Aoshi et al,
2008). Thus it seems that antigen presentation occurs in
various regions of the spleen, the precise location
presumably is dependent on the nature of the antigen, the
timing of the response and the different cell types involved.
The splenic MZ is a complex environment in which a
plethora of interactions among different cell types are
required for its function and maintenance. To understand
the role that MZ organization plays in NKTcell activation, we
have used genetic and chemical approaches to deplete var-
ious cellular populations in the MZ. Though CCL are widely
used to deplete macrophages (Van Rooijen and Sanders,
1994), it has been reported that other populations might be
affected very soon after CCL treatment (Aoshi et al, 2008) and
in line with this we observed a decrease in the number of
CD11c
high DCs. Perhaps unsurprisingly, disruption of both
macrophages and DCs results in a dramatic decrease in NKT
cell activation. However, at later times after substantial
recovery of the DC population, there was a partial rescue of
NKT cell activation after antigen administration. To further
investigate the emerging role of DCs in NKT cell activation,
we took advantage of the CD11c-DOG system that allows
depletion of DCs after administration of DT (Probst et al,
2005; Hochweller et al, 2008). However, as the depletion of
DCs in this system was accompanied by the concomitant
disappearance of splenic macrophages, we were unable to
deﬁnitively identify whether a unique population was
responsible for presenting antigen to NKT cells. Never-
theless, taken together our ﬁndings suggest that the
cooperation of both macrophages and DCs may be
necessary to achieve efﬁcient NKT cell responses. In line
with this, several studies support the idea that the cross
talk between DCs and macrophages promotes efﬁcient T
cell responses (Aichele et al, 2003; Backer et al, 2010; You
et al, 2011). Although DCs appear to play a major role in
antigen presentation to splenic Tcells, they are not absolutely
required as macrophages can act as substitutes in their
absence (Neuenhahn et al, 2006). Moreover in view of the
fact that MZ macrophages mediate efﬁcient antigen retention
(Aichele et al, 2003; Kang et al, 2004) it has been proposed
that they might retain antigen in the spleen and transfer it to
DCs to initiate efﬁcient T cell responses (Backer et al, 2010).
Intriguingly, even in the absence of DCs and macrophages,
we detected a signiﬁcant NKT cell activation in response to
blood-borne antigen indicating that other APCs such as B
cells may also participate in NKTcell activation in the spleen.
In conclusion, we have shown that the majority of NKT
cells are located in the MZ and RP, rendering them accessible
to blood-borne antigen and thereby facilitating their
rapid activation. As NKT cells have been implicated in a
wide variety of immune responses, such as following
infection or anti-tumour immunity, our observations provide
new insight into the regulation of NKT cell-mediated
immune responses that could lead to the design of improved
vaccination strategies.
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Antigens, lipid preparation and microsphere coating
aGalCer was purchased from Enzo Life Sciences. GalA-GSL was
kindly provided by Dr Mitchell Kronenberg (Division of Cell
Biology, La Jolla Institute for Allergy and Immunology, La Jolla,
CA 92037, USA). 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC)
was purchased from Avanti Polar Lipids. Liposomes containing
DOPC/aGalCer (90/10, w/w) or DOPC/GalA-GSL (90/10, w/w)
were prepared as described (Barral et al, 2010). For coating, silica
microspheres (200nm diameter; Kisker GbR) were incubated with
liposomes for 10min, washed with PBS containing 1% BSA (Sigma)
and 1% FCS (Gibco-Invitrogen) and resuspended in PBS.
Mice, cell lines and injections
Va14 TCR transgenic, CD11c-DOG, CD45.1 C57BL/6 and C57BL/6
WT mice were bred and maintained at the animal facility of Cancer
Research UK or the John Radcliffe Hospital, Oxford. All experiments
were approved by the Cancer Research UK, Animal Ethics
Committee and the United Kingdom Home Ofﬁce.
1–10ml stock of particles (B10
9particles/ml) were resuspended in
200ml PBS for i.v. injection. For CLL treatment mice were i.p.
injected with a standard suspension clodronate-loaded liposomes
2, 6, 16 or 22 days before analysis. Clodronate was a gift of Roche
Diagnostics GmbH. Other reagents for preparation of liposomes
(Van Rooijen and Sanders, 1994) were phosphatidylcholine (LIPOID
E PC; Lipoid GmbH) and cholesterol (Sigma).
For cell depletion in CD11c-DOG, mice were injected i.p. twice
with DT (8 ng/gram body weight) 48h before analyses (Hochweller
et al, 2008).
NKT hybridoma DN32.D3 was kindly provided by A. Bendelac
(University of Chicago, Chicago, IL).
Flow cytometry analysis of in vivo antibody labelling and NKT
cell activation
For in vivo antibody labelling experiments, mice were i.v. injected
with 2mg of anti-mouse CD45-PE or CD45-FITC antibody (104;
eBioscience) and sacriﬁced for tissue analyses 3 or 20min after
injection. Single-cell spleen suspensions for ﬂow cytometry were
obtained by mincing the tissue through a 70mm strainer followed by
erythrocyte lysis. Flow cytometry analyses were performed in FACS
buffer containing PBS, 1% BSA and 1% FCS. Anti-mouse CD16/32
(2.4G2, BD Biosciences) was used to block non-speciﬁc antibody
binding. Afterwards the following directly labelled anti-mouse
antibodies were used: B220-paciﬁc blue (RA3-6B2), TCR-b 
APCCy7 (H57-597), CD44-PECy5 (IM7) from BD Biosciences;
CD69-PE (H1.2F3) and CD122-PE (5H4) from eBioscience; CD4-PE
(GK1.5; Biolegend); CD8-PB (5H10; Caltag), and aGalCer loaded-
CD1d tetramer-APC (ProImmune). Anti-mouse CD21-FITC (7G6, BD
Biosciences) and anti-mouse CD23-APC (2G8, Southern Biotech)
were used to identify MZ and follicular B cells. Dead cells were
excluded from the analysis by staining with DAPI (2-(4-
Amidinophenyl)-6-indolecarbamidine dihydrochloride, Sigma).
For intracellular IFN-g and IL-4 staining single cell suspension
were prepared and stained with B220-paciﬁc blue, TCR-b-APC-Cy7
and aGalCer loaded-CD1d tetramer-APC prior to ﬁxation and per-
meabilization with Cytoﬁx/Cytoperm solutions (BD Biosciences).
Fixed cells were stained with anti-mouse IFN-g-FITC (XMG1.2, BD
Biosciences) or anti-IL-4-AlexaFluor 488 (11B11, BD Biosciences).
All data were collected on an LSRFortessa ﬂow cytometer (Becton
Dickinson) and were analysed with FlowJo software (TreeStar).
Isolation of DCs and SIGN-R1
þ macrophages, in vitro lipid
presentation assays and ELISA for IL-2
For puriﬁcation of splenic DCs and SIGN-R1
þ macrophages single-
cell spleen suspensions were prepared by treatment with collage-
nase IV and DNase I for 30min at 37C and mincing the tissue
through a 70mm strainer followed by erythrocyte lysis. B
and T cells were depleted by using Mouse Pan B and Pan
T Dynabeads (Invitrogen) prior to sorting with CD11c-FITC
(HL3, BD Biosciences) and SIGN-R1-Alexa 647 (22D1, eBioscience)
antibodies.
For analysis of aGalCer presentation, sorted cells were incubated
for 2h with 1ml of particles, washed 3 times and cultured (1–15 
10
4cells/well) with 5 10
4cells/well of DN32.D3 cells for 16h in 96
well U-bottom plates with 200ml of RPMI 1640 with 10% FCS. IL-2
concentration was determined by a standard sandwich ELISA in the
supernatant of the culture medium, using anti-IL-2 (JES6-1A12)
antibody for capture and biotinylated anti-IL-2 (JES6-5H4) antibody
for detection (both BD Pharmingen).
Isolation of NKT cells and adoptive transfer
NKT cells were puriﬁed by sorting from the spleen of Va14 TCR
transgenic mice as previously described (Barral et al, 2010). Purity
of the sample was conﬁrmed to be higher than 95% by staining with
aGalCer loaded-CD1d tetramer-APC. 2–3 10
6 puriﬁed NKT cells
were injected by tail vein injection in 4–6 week old C57BL/6 CD45.1
congenic recipients. For some experiments puriﬁed NKT cells were
labelled with SNARF-1 (Invitrogen) or CellTrace Violet (CTV,
Invitrogen) before transfer. After 16–20h recipients were injected
i.v. with 5ml of the stock of particulate lipids (B10
9particles/ml) or
with 2mg of anti-mouse CD45-PE.
Immunoﬂuorescence
For staining of endogenous TCR-b
þNK1.1
þ NKT cells mice were
under terminal anaesthesia and perfused with 10% neutral buffered
formalin before removal of the spleen for cryosections. Cryostat
sections (10mm thick) of spleen were blocked with PBS containing
1% BSA and 10% goat serum for 30min prior to incubation with
paciﬁc-blue rat anti-mouse B220 (RA3-6B2, BD Biosciences),
TCR-b PE (H57-597), CD169-FITC (3D6.112, AbDSerotec) and
NK1.1-APC (PK136, eBioscience). For detection of adoptively trans-
ferred NKT cells the following antibodies were used: B220-paciﬁc
blue (RA3-6B2, BD Biosciences), TCR-b PE (H57-597), CD169-FITC
(3D6.112, AbDSerotec) and CD45.2-APC (104, BD Biosciences).
Alternatively, sections were incubated with the following anti-
mouse antibodies: B220-Alexa 647 (RA3-6B2, BD Biosciences),
F4/80-Alexa 647 (CI:A3-1, Biolegend), B220-FITC (RA3-6B2, BD
Biosciences), CD169-FITC (3D6.112, AbDSerotec), MARCO-FITC
(ED31, AbDSerotec), SIGNR1-Alexa 647 (22D1, eBioscience) and
hamster anti-mouse CD11c (N418, Caltag), followed by Alexa 647-
conjugated goat anti-hamster IgG (Molecular Probes) and Alexa 488-
conjugated anti-ﬂourescein/Oregon green rabbit IgG (Molecular
Probes) when FITC-labelled antibodies were used. Imaging was
carried out on a LSM 710s (Zeiss) inverted confocal microscope.
Multi-photon microscopy imaging of the spleen
2–3 10
6 puriﬁed NKT cells were labelled with SNARF-1 and
injected by tail vein injection in 4–6 weeks old WT recipients
together with the same number of CMAC labelled T cells. For
multi-photon microscopy imaging, spleens were attached to the
base of a glass-bottom 35mm culture dish by veterinary topical
tissue adhesive and were continuously perfused with warmed
(371C) RPMI 1640 medium without Phenol Red (GIBCO,
Invitrogen) and bubbled with carbogen (95% O2,5 %C O 2). For
imaging of deep spleen regions, thick sections of fresh spleen
(1–2mm) were obtained by transversally cutting the tissue with a
sharp scalpel (as previously reported (Khanna et al, 2007)). Sections
were glued to a culture dish on the resected surface and perfused
with warmed oxygenated medium as described above. The system
was set up inside the environmental chamber that covers the
microscope, maintaining a temperature of 371C throughout the
imaging session. Image acquisition was performed with an
upright multi-photon microscope (Olympus Fluoview FV1000
MPE2 Twin system) using a water-immersion 25 1.05 NA
objective (Olympus XLPLNWMP) and a pulsed Ti:sapphire laser
(Spectra Physics MaiTai HP DeepSee) tuned to provide an excitation
wavelength of 800nm. For four-dimensional imaging (x, y, z, and
time), stacks of 11–20 square xy planes spanning 508mm by 508mm
with 5mm z spacing were acquired over 20–30min (30–40 time-
points). Emission wavelengths were detected through 420–500nm
(CMAC), 515–560nm (green ﬂuorescent particles) and 590–650nm
(SNARF-1) band-pass ﬁlters. Sequences of image stacks were
transformed into volume-rendered four-dimensional movies and
analysed with Imaris 6.3 64 software (Bitplane).
Data analysis
Analysis of four-dimensional multi-photon movies was performed
using Imaris 6.3 64 software (Bitplane). The average speed of
individual cells was calculated as path length over time (mm/min).
Arrest coefﬁcient was calculated as the percentage of each track in
which the cell moved more slowly than 2mm/min. The x, y and z
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Tracks normalized at the same departure point were plotted with
MatLab (The Mathworks Inc.).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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